Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use

Launched by MEDISYS HEALTH NETWORK · Dec 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how effective a local anesthetic called Bupivacaine, combined with epinephrine, is when injected into the vaginal cuff (the area left after a hysterectomy) before the surgery is finished. The main goal is to see if this injection helps reduce the amount of pain medication needed immediately after the surgery and to improve overall comfort and satisfaction for patients.

To be eligible for this study, participants must be women aged 18 and older who are scheduled for a total laparoscopic hysterectomy. This type of surgery involves removing the uterus through small incisions in the abdomen. Some women with benign (non-cancerous) conditions or even those with cancer may qualify. However, individuals with certain health issues or those who have had multiple previous surgeries may not be able to participate. If you join the trial, you can expect to receive the local anesthetic during your procedure, and researchers will monitor your pain levels and medication use afterward to understand how well this approach works.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients 18 years and older requiring total laparoscopic hysterectomy with or without bilateral salpingo-oophorectomy for benign conditions
• • Presence of malignancy
• Exclusion Criteria:
• • Conversion to laparotomy
• • Previous multiple abdominal and/or pelvic surgeries
• • Significant medical comorbidities or cardiac history
• • Poor initial Aldrete score4 (\<10)
• • Significant pre-op pain medication use
• • Contraindication to any medication that would be used in the study (Bupivacaine, epinephrine, tramadol or oxycodone)